Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schachter

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Cancer|February 22, 2002
Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapyHaim Gutman, Jacob Schachter, Ella Stopel, et al.
Oncotarget|February 18, 2016
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cellsShira Ashkenazi, Rona Ortenberg, Michal Besser, et al.
Melanoma Research|February 6, 2003
Patterns of failure in patients with malignant melanoma treated with high-dose interferon-alpha2b in the adjuvant settingJacob Schachter, Baruch Brenner, Eyal Fenig, et al.
European Radiology|March 26, 2014
CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastasesShai Shrot, Jacob Schachter, Ronnie Shapira-Frommer, et al.
American Journal of Clinical Oncology|December 10, 2003
Primary squamous cell carcinoma (SqCC) of the breastTehillah Menes, Jacob Schachter, Sarah Morgenstern, et al.
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Adoptive Cell Therapy for Metastatic MelanomaEfrat Merhavi-Shoham, Orit Itzhaki, Gal Markel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 7, 2002
Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive componentNir Wasserberg, Sarah Morgenstern, Jacob Schachter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 24, 2004
Lymphatic drainage to the popliteal basin in distal lower extremity malignant melanomaTehillah S Menes, Jacob Schachter, Adam P Steinmetz, et al.
Oncology Reports|January 10, 2015
A longitudinal study of CEACAM1 expression in melanoma disease progressionDouglas Zippel, Hani Barlev, Rona Ortenberg, et al.
Cancer|May 26, 2017
Adoptive T cell therapy: An overview of obstacles and opportunitiesErez Nissim Baruch, Amy Lauren Berg, Michal Judith Besser, et al.
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Cancer|February 22, 2002
Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapyHaim Gutman, Jacob Schachter, Ella Stopel, et al.
Oncotarget|February 18, 2016
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cellsShira Ashkenazi, Rona Ortenberg, Michal Besser, et al.
Melanoma Research|February 6, 2003
Patterns of failure in patients with malignant melanoma treated with high-dose interferon-alpha2b in the adjuvant settingJacob Schachter, Baruch Brenner, Eyal Fenig, et al.
European Radiology|March 26, 2014
CT halo sign as an imaging marker for response to adoptive cell therapy in metastatic melanoma with pulmonary metastasesShai Shrot, Jacob Schachter, Ronnie Shapira-Frommer, et al.
American Journal of Clinical Oncology|December 10, 2003
Primary squamous cell carcinoma (SqCC) of the breastTehillah Menes, Jacob Schachter, Sarah Morgenstern, et al.
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Adoptive Cell Therapy for Metastatic MelanomaEfrat Merhavi-Shoham, Orit Itzhaki, Gal Markel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 7, 2002
Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive componentNir Wasserberg, Sarah Morgenstern, Jacob Schachter, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 24, 2004
Lymphatic drainage to the popliteal basin in distal lower extremity malignant melanomaTehillah S Menes, Jacob Schachter, Adam P Steinmetz, et al.
Oncology Reports|January 10, 2015
A longitudinal study of CEACAM1 expression in melanoma disease progressionDouglas Zippel, Hani Barlev, Rona Ortenberg, et al.
Cancer|May 26, 2017
Adoptive T cell therapy: An overview of obstacles and opportunitiesErez Nissim Baruch, Amy Lauren Berg, Michal Judith Besser, et al.
Pageof 16